Common and rare susceptibility genetic variants predisposing to Brugada syndrome in Thailand.


Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
12 2020
Historique:
received: 14 04 2020
revised: 06 06 2020
accepted: 23 06 2020
pubmed: 4 7 2020
medline: 30 9 2021
entrez: 4 7 2020
Statut: ppublish

Résumé

Mutations in SCN5A are rarely found in Thai patients with Brugada syndrome (BrS). Recent evidence suggested that common genetic variations may underlie BrS in a complex inheritance model. The purpose of this study was to find common and rare/low-frequency genetic variants predisposing to BrS in persons in Thailand. We conducted a genome-wide association study (GWAS) to explore the association of common variants in 154 Thai BrS cases and 432 controls. We sequenced SCN5A in 131 cases and 205 controls. Variants were classified according to current guidelines, and case-control association testing was performed for rare and low-frequency variants. Two loci were significantly associated with BrS. The first was near SCN5A/SCN10A (lead marker rs10428132; odds ratio [OR] 2.4; P = 3 × 10 The genetic basis of BrS in Thailand includes a wide spectrum of variant frequencies and effect sizes. As previously shown in European and Japanese populations, common variants near SCN5A and HEY2 are associated with BrS in the Thai population, confirming the transethnic transferability of these 2 major BrS loci.

Sections du résumé

BACKGROUND
Mutations in SCN5A are rarely found in Thai patients with Brugada syndrome (BrS). Recent evidence suggested that common genetic variations may underlie BrS in a complex inheritance model.
OBJECTIVE
The purpose of this study was to find common and rare/low-frequency genetic variants predisposing to BrS in persons in Thailand.
METHODS
We conducted a genome-wide association study (GWAS) to explore the association of common variants in 154 Thai BrS cases and 432 controls. We sequenced SCN5A in 131 cases and 205 controls. Variants were classified according to current guidelines, and case-control association testing was performed for rare and low-frequency variants.
RESULTS
Two loci were significantly associated with BrS. The first was near SCN5A/SCN10A (lead marker rs10428132; odds ratio [OR] 2.4; P = 3 × 10
CONCLUSION
The genetic basis of BrS in Thailand includes a wide spectrum of variant frequencies and effect sizes. As previously shown in European and Japanese populations, common variants near SCN5A and HEY2 are associated with BrS in the Thai population, confirming the transethnic transferability of these 2 major BrS loci.

Identifiants

pubmed: 32619740
pii: S1547-5271(20)30626-3
doi: 10.1016/j.hrthm.2020.06.027
pii:
doi:

Substances chimiques

NAV1.5 Voltage-Gated Sodium Channel 0
SCN5A protein, human 0
DNA 9007-49-2

Banques de données

ClinicalTrials.gov
['NCT04232787']

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2145-2153

Informations de copyright

Copyright © 2020 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Pattarapong Makarawate (P)

Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

Charlotte Glinge (C)

Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands; The Heart Centre, Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Apichai Khongphatthanayothin (A)

Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Bangkok Heart Hospital, Bangkok General Hospital, Bangkok, Thailand. Electronic address: apichaik@yahoo.com.

Roddy Walsh (R)

Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.

John Mauleekoonphairoj (J)

Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Montawatt Amnueypol (M)

Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Somchai Prechawat (S)

Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Wanwarang Wongcharoen (W)

Department of Medicine, Faculty of Medicine, Chiangmai University, Chiangmai, Thailand.

Rungroj Krittayaphong (R)

Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Alisara Anannab (A)

Department of cardiovascular and intervention, Central Chest Institute of Thailand, Nonthaburi, Thailand.

Peter Lichtner (P)

Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.

Thomas Meitinger (T)

Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.

Fleur V Y Tjong (FVY)

Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.

Krystien V V Lieve (KVV)

Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.

Ahmad S Amin (AS)

Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.

Dujdao Sahasatas (D)

Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

Tachapong Ngarmukos (T)

Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Duangdao Wichadakul (D)

Department of Computer Engineering, Faculty of Engineering, Chulalongkorn University, Bangkok, Thailand.

Sunchai Payungporn (S)

Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Boosamas Sutjaporn (B)

Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Pharawee Wandee (P)

Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Yong Poovorawan (Y)

Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Jacob Tfelt-Hansen (J)

The Heart Centre, Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Department of Forensic Medicine, Faculty of Medical Sciences, University of Copenhagen, Copenhagen, Denmark; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART; http://guardheart.ern-net.eu).

Michael W T Tanck (MWT)

Amsterdam UMC, University of Amsterdam, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam Public Health, Amsterdam, The Netherlands.

Rafik Tadros (R)

Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands; Department of Medicine, Cardiovascular Genetics Center, Montreal Heart Institute and Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.

Arthur A M Wilde (AAM)

Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART; http://guardheart.ern-net.eu).

Connie R Bezzina (CR)

Amsterdam UMC, University of Amsterdam, Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART; http://guardheart.ern-net.eu).

Gumpanart Veerakul (G)

Bangkok Heart Hospital, Bangkok General Hospital, Bangkok, Thailand.

Koonlawee Nademanee (K)

Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Pacific Rim Electrophysiology Research Institute, Bumrungrad Hospital, Bangkok, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH